Reduce risks and discover creative solutions for complex disputes.
Drug and device cases require adjudicators to weigh general and specific causation, FDA labeling decisions, and years of event data. A bellwether verdict can set the value of thousands of cases, making Daubert and Rule 702 preparation, preemption arguments, and the positioning of manufacturers' internal documents the first steps in our approach to developing a strategic roadmap for clients to reduce litigation risk.
IMS brings decades of experience supporting both sides of some of the most significant decisions in pharmaceutical and medical device disputes. We work with legal teams on behalf of brand and generic drug makers, medical device and implant manufacturers, distributors, and the patients and payers bringing these claims. Representative dispute types include:
- Product liability: design defect, manufacturing defect, and failure to warn
- Mass tort MDLs, bellwether trials, and consumer class actions
- Medical device and implant failures, recalls, and FDA 483 or warning letter disputes
- Off-label promotion, False Claims Act, and qui tam actions
- Patent infringement, trade secret, and licensing disputes
- Antitrust, drug pricing, and reverse-payment (pay-for-delay) claims
- False advertising and Lanham Act claims
Am Law and boutique firms nationwide rely on IMS for credible, non-conflicted experts to weigh consumer perception, credible data on how jurors view the case issues, and cohesive strategies that strengthen the case throughout the lifecycle of a claim, whether in MDL courts, state coordinated proceedings, federal and state trials, or arbitration. Read more below.